KATHRYN STEENSTRA: Open Payments
NPI 1265771372 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,292 in 29 payments from 13 companies in 2025. Trend: 2023 $385 · 2024 $465 · 2025 $1,292
Food & beverage: $1,292
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $454 |
| E.R. Squibb & Sons, L.L.C. | 2 | $210 |
| Legend Biotech USA Inc. | 6 | $156 |
| Syndax Pharmaceuticals, Inc. | 1 | $113 |
| JAZZ PHARMACEUTICALS INC. | 4 | $111 |
| SANOFI-AVENTIS U.S. LLC | 2 | $74 |
| Genmab U.S., Inc. | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Incyte Corporation | 1 | $24 |
Products named: RYBREVANT, CARVYKTI, REVUFORJ, REZUROCK, DEFITELIO, EPKINLY, RYLAZE, DARZALEX.
Industry payments across AZ — which companies pay providers there.
